Bachy V., Ballerini C., Gourdain P., Prignon A., Iken S., et al. Mouse vaccination with dendritic cells loaded with prion protein peptides overcomes tolerance and delays scrapie. J. Gen. Virol. 2010, 91:809-820.
Beers D., Zhao W., Liao B., Kano O., Wang J., Appel S., Henkel J.S. Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice. Brain Behav. Immun. 2011, 25(5):1025-1035.
Bendheim P.E., Brown H.R., Rudelli R.D., Scala L.J., Goller N.L., et al. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 1992, 42:149-156.
Beringue V., Vilette D., Mallinson G., Archer F., Kaisar M., et al. PrPSc binding antibodies are potent inhibitors of prion replication in cell lines. J. Biol. Chem. 2004, 279:39671-39676.
Betmouni S., Perry V.H., Gordon J.L. Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience 1996, 74:1-5.
Branger C., Sonrier C., Chatrenet B., Klonjkowski B., Ruvoen-Clouet N., Aubert A., André-Fontaine G., Eloit M. Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect. Immun. 2001, 69:6831-6854.
Brochard V., Combadiere B., Prigen A., Laouar Y., Perrin A., Beray-Berthat V., Bonduelle O., et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J. Clin. Invest. 2009, 119:182-192.
Buc-Caron M.H., Launay J.M., Lamblin D., Kellermann O. Serotonin uptake, storage, and synthesis in an immortalized committed cell line derived from mouse teratocarcinoma. Proc. Natl. Acad. Sci. USA 1990, 87:1922-1926.
Chess L., Jiang H. Resurrecting CD8+ suppressor T cells. Nat. Immunol. 2004, 5:469-471.
Correale J., Villa A. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis. J. Neuroimmunol. 2008, 195:121-124.
Eikelenboom P., Bate C., Van Gool W.A., Hoozemans J.J.M., Rozemuller J.M., Veerhuis R., et al. Neuroinflammation in Alzheimer's disease and prion disease. Glia. 2002, 40:232-239.
Ethell D.W., Shippy D., Cao C., Cracchiolo J.R., Runfeld M., Blake B. Aβ-specific T-cells reverse cognitive decline and synaptic loss in Azheimer's mice. Neurobiol. Disease 2006, 23:351-361.
Ferrer I., Boada Rovira M., Sanchez Guerra M.L., Rey M.J., Costa-Jussa F. Neuropathology and pathogenesis of encephalitis following amyloid-β immunization in Alzheimer's disease. Brain Pathol. 2004, 14(1):11-20.
Fernandez-Borges N., Brun A., Whitton J.L., Parra B., Diaz-San Segundo F. DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge. J. Virol. 2006, 80:9970-9976.
Gilman S., Koller M., Black R.S., Jenkins L., Griffith S.G., Fox N.C., et al. Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial. Neurology 2005, 64:1553-1562.
Gourdain P., Gregoire S., Iken S., Bachy V., Dorban G., et al. Adoptive transfer of T lymphocytes sensitized against the prion protein attenuates prion invasion in scrapie-infected mice. J. Immunol. 2009, 183:6619-6628.
Gregoire S., Logre C., Metharom P., Loing E., Chomilier J., et al. Identification of two immunogenic domains of the prion protein-PrP-which activate class II-restricted T cells and elicit antibody responses against the native molecule. J. Leukoc. Biol. 2004, 76:125-134.
Gross D.A., Graff-Dubois S., Opolon P., Cornet S., Alves P., Bennaceur-Gricelli A., Faure O., et al. High vaccination efficiency of low-affinity epitopes in anti-tumor immunotherapy. J. Clin. Invest. 2004, 113(3):425-433.
Iken S., Bachy V., Gourdain P., Lim A., Gregoire S., Chaigneau T., Aucouturier P., Carnaud C. Th2-polarized PrP-specific transgenic T-cells confer partial protection against murine scapie. Plos Path. 2011, 7:e1002216.
Isaacs J.D., Ingram R.J., Collinge J., Altmann D.M., Jackson G.S. The human prion protein residue 129 polymorphism lies within a cluster of epitopes for T cell recognition. J. Neuropathol. Exp. Neurol. 2006, 65:1059-1068.
Joly E., Oldstone M.B. Neuronal cells are deficient in loading peptides onto MHC class I molecules. Neuron 1992, 8:1185-1190.
Kaiser-Schulz G., Heit A., Quintanilla-Martinez L., Hammerschmidt F., Hess S., et al. Polylactide-coglycolide microspheres co-encapsulating recombinant tandem prion protein with CpG-oligonucleotide break self-tolerance to prion protein in wild-type mice and induce CD4 and CD8 T cell responses. J. Immunol. 2007, 179:2797-2807.
Lewicki H., Tishon A., Homann D., Mazarguil H., Laval F., et al. T cells infiltrate the brain in murine and human transmissible spongiform encephalopathies. J. Virol. 2003, 77:3799-3808.
Levavasseur E., Metharom P., Dorban G., Nakano H., Kakiuchi T., et al. Experimental scrapie in 'plt' mice. an assessment of the role of dendritic-cell migration in the pathogenesis of prion diseases. J. Gen. Virol. 2007, 88:2353-2360.
Leifert J.A., Rodriguez-Carreno M.P., Rodriguez F., Whitton J.L. Targeting plasmid-encoded proteins to the antigen presentation pathways. Immunol. Rev. 2004, 199:40-53.
Ma J., Lindquist S. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science 2002, 298:1785-1788.
Marella M., Chabry J. Neurons and astrocytes respond to prion infection by inducing microglia recruitment. J. Neurosci. 2004, 24(3):620-627.
Mars L.T., Saikali P., Liblau R.S., Arbour N. Contribution of CD8 T lymphocytes to the immunopathogenesis of multiple sclerosis and its animal models. Biochem. Biophy. Acta 2011, 1812:151-161.
Mars L.T., Bauer J., Gross D.A., Bucciarelli F., Firat H., Hudrisier D., Lemonnier F., Kosmatopoulos K., Liblau R. CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A0201-transgenic mice. J. Immunol. 2007, 179:5090-5098.
Mc Farland H.F., Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 2007, 8:913-919.
Medana I.M., et al. MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not perforin pathway. Eur. J. Immunol. 2000, 30:3623-3633.
Mouillet-Richard S., Mutel V., Loric S., Tournois C., Launay J.M., Kellermann O. Regulation by neurotransmitter receptors of serotonergic or catecholaminergic neuronal cell differentiation, J. Biol. Chem. 2000, 275:9186-9192.
Neumann H., Medana I.M., Bauer J., Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS disease. Trends in Neurosci. 2002, 25:313-319.
Pankiewicz J., Prelli F., Sy M.S., Kascsak R.J., Kascsak R.B., et al. Clearance and prevention of prion infection in cell culture by anti-PrP antibodies. Eur. J. Neurosci. 2006, 23:2635-2647.
Peretz D., Williamson R.A., Kaneko K., Vergara J., Leclerc E., et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 2001, 412:739-743.
Pilon J., Loiacono C., Okeson D., Lund S., Vercauteren K., et al. Anti-prion activity generated by a novel vaccine formulation. Neurosci. Lett. 2007, 429:161-164.
Polymenidou M., Heppner F.L., Pellicioli E.C., Urich E., Miele G., et al. Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proc. Natl. Acad. Sci. USA 2004, 101:14670-14676.
Prusiner S.B., Scott M.R., DeArmond S.J., Cohen F.E. Prion protein biology. Cell 1998, 93:337-348.
Rosset M.B., Ballerini C., Gregoire S., Metharom P., Carnaud C., et al. Breaking immune tolerance to the prion protein using prion protein peptides plus oligodeoxynucleotide-CpG in mice. J. Immunol. 2004, 172:5168-5174.
Rosset M.B., Sacquin A., Lecollinet S., Chaigneau T., Adam M., et al. Dendritic cell-mediated-immunization with xenogenic PrP and adenoviral vectors breaks tolerance and prolongs mice survival against experimental scrapie. PLoS ONE 2009, 4:e4917.
Sacquin A., Bergot A.S., Aucouturier P., Bruley-Rosset M. Contribution of antibody and T cell-specific responses to the progression of 139A-scrapie in C57BL/6 mice immunized with prion protein peptides. J. Immunol. 2008, 181:768-775.
Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999, 400:173-177.
Souan L., Tal Y., Felling Y., Cohen I.R., Taraboulos A., et al. Modulation of proteinase-K resistant prion protein by prion peptide immunization. Eur. J. Immunol. 2001, 31:2338-2346.
Tal Y., Souan L., Cohen I.R., Meiner Z., Taraboulos A., et al. Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice. J. Neurosci. Res. 2003, 71:286-290.
Tennakoon D.K., Mehta R.S., Ortega S.B., Tennakoon M.K., Racke R.J., Karandikar N.J. Therapeutic induction of regulatory, cytotoxic CD8+ T cells in Multiple Sclerosis. J. Immunol. 2006, 176:7119-7129.
Tine J.A., Firat H., Payne A., Russo G., Davis S.W., et al. Enhanced multiepitope-based vaccines elicit CD8+ cytotoxic T cells against both immunodominant and cryptic epitopes. Vaccine 2005, 23:1085-1091.
Tourdot S., Oukka M., Manuguerra J.C., Magafa V., Vergnon I., et al. Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity: application in antiviral vaccination. J. Immunol. 1997, 159:2391-2398.
Van der Burg S.H., Visseren M.J.W., Brandt R.M.P., Kast W.M., Melief C.J.M. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 1996, 156:3308-3314.
White A.R., Enever P., Tayebi M., Mushens R., Linehan J., et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 2003, 422:80-83.
Yewdell J.W., Bennink J.R. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 1999, 17:51-88.
Zozuyla A.L., Wiendl H. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation. Hum. Immunol. 2008, 69(11):797-804.
